Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
International Cooperations

International Cooperations

Contact

Dr. Claudia Mayer
International Cooperations

Tel: +49 6221 42 2653
c.mayer (at) dkfz.de

The German Cancer Research Center (DKFZ) is Germany's largest biomedical research institute, with world- class research in all fields of cancer research, state-of-the-art facilities for high-through-put genome sequencing and other "-omics" technologies.
DKFZ has strong partnerships with other universities, research institutes, and industry partners, both in Europe and worldwide, which is essential to maintain the level of world-class excellence in research and education of young research talents.

The main international cooperation partners are:

MD Anderson Cancer Center, Houston, USA

The DKFZ has collaborated with the MD Anderson Cancer Center (MDACC) in Houston since 2008, and the relationship was made official with an agreement to join forces as sister institutes. Collaborations between the two centers have included numerous joint projects in basic and translational research, as well as short-term research visits for junior scientists.

https://www.mdanderson.org

Princess Margaret Cancer Center, Toronto, Canada

The DKFZ and Princess Margaret Cancer Centre in Toronto have the joint mission to accelerate the discovery process that leads to improved patient treatment and care. The centers signed a joint memorandum of understanding in September 2017 that underlined their commitment to work together towards this goal by establishing internationally highly competitive research and training programs. A particular focus will be on the development of an initiative for training clinician scientists and medical scientists.

http://www.uhn.ca/PrincessMargaret

National Cancer Institute NCI, Bethesda, USA

Existing interactions between the DKFZ and the NCI have intensified since 2017 with a series of joint thematic workshops. These workshops were the first step in the establishment of a series of collaborative programs in topics ranging from Radiooncology to Cancer Systems Biology. 

https://www.cancer.gov

International Agency for Research on Cancer IARC, Lyon, France

In 2019, the DKFZ and the International Agency for Research on Cancer IARC signed a Memorandum of Understanding expressing their commitment to join forces in strengthening the evidence-base that underpins cancer prevention and control.

https://www.iarc.who.int 

Tianjin Medical University Cancer Institute & Hospital, China

The DKFZ and the Tianjin Medical University Cancer Institute & Hospital in China join forces through common research projects, training and education of young scientist and joint scientific events in the field of cancer precision medicine.

DKFZ-MOST Program in Cancer Research, Israel

The aim of the DKFZ-MOST (Ministry of Science and Technology) Program in Cancer Research is to enhance collaborations between DKFZ scientists and researchers at all scientific institutions in Israel. Funding of yearly 18 joint projects with a duration of three years is at the core of this program, which was founded in 1976). Regular scientific workshops as well as schools for junior researchers complement the program, and have led not only to numerous significant scientific advances but also fostered faith and friendship between Israeli and DKFZ scientists.

https://www.dkfz.de/en/israel/index.html

Weizmann Institute of Science, Rehovot, Israel

The German-Israeli Helmholtz Research School in Cancer Biology was established in 2012 on the basis of a long-term scientific cooperation between the DKFZ and the Weizmann Institute of Science in Rehovot. The graduate school offers the unique opportunity to carry out doctoral research in an international environment, as well as to spend a few months studying at the partner institute. Since 2018, the graduate school has been expanded to include bridging positions that support students before and after their graduate studies (Cancer-Trax program).

https://www.dkfz.de/en/phd-program/GIHRS.html

Inserm (Institute national de la santé et de la recherche médicale), France

The French Institute national de la santé et de la recherche médicale (Inserm) has hosted the DKFZ-Inserm Unit “Microbiology and Infectious Diseases” since 2012. The Unit is led by H-J Delecluse, whose research focuses on cancers associated with Epstein-Barr virus.

https://www.dkfz.de/en/f100/research.html

University of Namibia and Ministry of Health and Social Services, Namibia

In September 2019 the DKFZ, the Ministry of Health and Social Services of Namibia and the University of Namibia signed a Memorandum of Understanding to collaborate in cancer research and in education and training programs. The focus of this partnership is on cancer prevention strategies and imaging based cancer diagnostic technologies.

National Hellenic Research Foundation / Athens Comprehensive Cancer Center, Greece

The DKFZ is working together with colleagues in Greece to establish the Athens Comprehensive Cancer Center. The cooperation is focused on collaborative international research activities and exchange visits for scientists. It is supported by the Helmholtz Association’s Initiative and Networking Fund, in the scope of the European Partnering Program. 

Cancer Core Europe

In the Cancer Core Europe consortium, the DKFZ and NCT have joined together with six other leading European Comprehensive Cancer Centers, the Cambridge Cancer Center, Gustave Roussy in Villjuif near Paris, the Netherlands Cancer Institute in Amsterdam, the Karolinska Institutet in Stockholm, the Vall d’Hebron Institute of Oncology in Barcelona, and the Istituto Nazionale die Tumori in Milan. These centers form a united infrastructure for carrying out innovative projects and clinical studies in the areas of personalized cancer medicine. The goal is to accelerate the transfer of research results into clinical application for the benefit of patients in Europe.

https://www.cancercoreeurope.eu

Cancer Prevention Europe

The DKFZ is involved in the European initiative Cancer Prevention Europe, coordinated by the International Agency for Research on Cancer (IARC). Cancer Prevention Europe is a newly established alliance that will bring together coordination, research and training in the area of cancer prevention at the European level. It will address areas including, for example, cancer registries, cancer etiology, and the evaluation of interventional measures for cancer prevention. 

to top
powered by webEdition CMS